Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00369330
Status:
WITHDRAWN
Last Update Posted:
2012-09-03
First Post:
2006-08-28
Brief Title:
KONVERT-AF - Relevance of Point in Time for Conversion of Acute Atrial Fibrillation
Sponsor:
Atrial Fibrillation Network
Organization:
Atrial Fibrillation Network
Study Overview
Official Title:
Prospective Randomized Parallel-group Study for Evaluation of Impact of Early Versus Delayed Cardioversion of Acute Atrial Fibrillation on Further Clinical Course
Status:
WITHDRAWN
Status Verified Date:
2006-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
withdrawn because of insufficient financial capacities
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate if in acute symptomatic atrial fibrillation AF the early 2 hrs but within 12 hrs of the beginning of the arrhythmia electrical cardioversion leads to a longer recurrence-free interval than the delayed cardioversion 36 hrs but 48 hrs after the beginning of the arrhythmia within the first 3 months after cardioversion
Detailed Description:
So far it is unknown if early or delayed cardioversion is most beneficial for patient outcome and which strategy is best to prevent recurrence of AF The KONVERT-AF trial investigates if in acute symptomatic AF the early 2 hrs but within 12 hrs of the beginning of the arrhythmia electrical cardioversion leads to a longer recurrence-free interval than the delayed cardioversion 36 hrs but 48 hrs after the beginning of the arrhythmia within the first 3 months after cardioversion Primary endpoint is the time to the first recurrence of AF The KONVERT-AF trial will be conducted as prospective randomized non-blinded multicentre study It is planned to include 380 patients in 10-20 recruitment centres
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None